Emerald Wealth Partners, an independent asset and wealth management firm based in Zurich, released its Q4 2025 investor letter for the “Growth Equity Strategy.” A copy of the letter is available to ...

Thermo Fisher Scientific Inc. (NYSE:TMO) is one of Goldman Sachs top healthcare stocks. On March 3 at the 47th Annual Raymond James Institutional Investor Conference, CEO Marc Casper outlined a strong ...

Add Yahoo as a preferred source to see more of our stories on Google. Thermo Fisher has committed to a $125m payment in January 2027. Credit: JHVEPhoto / Shutterstock.com. (JHVEPhoto / ...

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, today announced a strategic data collaboration with Datavant, the data collaboration platform trusted ...

Thermo Fisher Scientific will close its Franklin facility between late 2026 and late 2027. The closure of the biologics storage and cell therapy plant will result in the loss of 103 jobs. The action ...

Thermo Fisher Scientific plans to close a manufacturing facility in Franklin at the end of the year but will not lay off as many employees as the Waltham-based scientific tools maker said it would ...

Biopharma tools and services provider Thermo Fisher Scientific is set to lay off more than 100 workers as the Waltham-based firm is closing its Franklin facility amid an executive shakeup. Thermo ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Thermo Fisher Scientific is ...

Shares of Thermo Fisher Scientific (TMO) pared premarket gains on Thursday as the life sciences company issued underwhelming guidance during its earnings call after reporting better-than-expected Q4 ...

Thermo Fisher Scientific on Thursday forecast annual profit below Wall Street estimates, expecting pressure from cuts to U.S. academic research to spill into 2026, sending its shares down 2.24%. The ...

AI-generated summary reviewed by our newsroom. Read our AI Policy. Plant will cease operations by end of 2026; layoffs continue into 2027. Company will phase out operations and transfer product lines ...

A global life sciences manufacturer with a presence in Mebane plans to close its plant north of Asheville over the next two years, laying off more than 400 workers. In a Jan. 8 letter to the N.C.